EUVIMEDEUVIMED entdecken
Validierungsstudie

External Validation of the fullPIERS Risk Prediction Model in a U.S. Cohort of Individuals with Preeclampsia

Danielle Long, Kari Flicker, Maya Vishnia, Madeleine Wright, Matilda Francis, Kenyone S King, Lauren Gilgannon, Aref Rastegar, Neha Gupta, Rohini Kousalya Siva, Lea Nehme, Tetsuya Kawakita iD

American Journal of Perinatology · 01.06.2025 · 42 (08) · 1035-1042

DOI: 10.1055/a-2452-8220 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.06.2025. Verfasst von Danielle Long und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences at Old Dominion University (ODU), Norfolk, Virginia. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Eastern Virginia Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to externally validate the Preeclampsia Integrated Estimate of Risk (fullPIERS) risk prediction model in a cohort of pregnant individuals with preeclampsia in the United States. This was a retrospective study of individuals with preeclampsia who delivered at 22 weeks or greater from January 1, 2010, to December 31, 2020. The primary outcome was a composite of maternal mortality or other serious complications of preeclampsia occurring within 48 hours of admission. We calculated the probability of the composite outcome using the fullPIERS prediction model based on data available within 12 hours of admission, including gestational age, chest pain or dyspnea, serum creatinine levels, platelet count, aspartate transaminase levels, and oxygen saturation. We assessed the model performance using the area under the curve (AUC) of the receiver operating characteristic curve. The optimal cutoff point was determined using Liu's method. A calibration plot was used to evaluate the model's goodness-of-fit. Among 1,510 individuals with preeclampsia, 82 (5.4%) experienced the composite outcome within 48 hours. The fullPIERS model achieved an AUC of 0.80 (95% confidence interval [CI]: 0.75–0.86). The predicted probability for individuals with the composite outcome (median: 18.8%; interquartile range: 2.9–59.1) was significantly higher than those without the outcome (median: 0.9%; interquartile range: 0.4–2.7). The optimal cutoff point of 5.5% yielded a sensitivity of 70.7% (95% CI: 59.6–80.3), a specificity of 85% (95% CI: 82.7–86.5), a positive likelihood ratio of 4.6 (95% CI: 3.8–5.5), and an odds ratio of 13.3 (95% CI: 8.1–21.8). The calibration plot indicated that the model underestimated risk when the predicted probability was below 1% and overestimated risk when the predicted probability exceeded 5%. The fullPIERS model demonstrated good discrimination in this U.S. cohort of individuals with preeclampsia, suggesting it may be a useful tool for health care providers to identify individuals at risk for severe complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaHumansFemalePregnancyRetrospective StudiesAdultRisk AssessmentUnited StatesROC CurveArea Under CurveMaternal MortalityGestational AgeCreatinine

Substanzen

Creatinine

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences at Old Dominion University (ODU), Norfolk, Virginia.
  • Department of Obstetrics and Gynecology, Jefferson Health - New Jersey, Cherry Hill, New Jersey.
  • Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
  • Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia.
  • Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia.

ORCID-Profile: Tetsuya Kawakita

Förderung

  • Eastern Virginia Medical School

Zitieren

APA

Long, D., Flicker, K., Vishnia, M., Wright, M., Francis, M., King, K. S., Gilgannon, L., Rastegar, A., Gupta, N., Kousalya Siva, R., Nehme, L., & Kawakita, T. (2025). External Validation of the fullPIERS Risk Prediction Model in a U.S. Cohort of Individuals with Preeclampsia. American Journal of Perinatology, 42(08), 1035-1042. https://doi.org/10.1055/a-2452-8220

Vancouver

Long D, Flicker K, Vishnia M, Wright M, Francis M, King KS, et al. External Validation of the fullPIERS Risk Prediction Model in a U.S. Cohort of Individuals with Preeclampsia. American Journal of Perinatology. 2025;42(08):1035-1042. doi:10.1055/a-2452-8220

BibTeX
@article{Long2025,
  author = {Long, Danielle and Flicker, Kari and Vishnia, Maya and Wright, Madeleine and Francis, Matilda and King, Kenyone S and Gilgannon, Lauren and Rastegar, Aref and Gupta, Neha and Kousalya Siva, Rohini and Nehme, Lea and Kawakita, Tetsuya},
  title = {External Validation of the fullPIERS Risk Prediction Model in a U.S. Cohort of Individuals with Preeclampsia},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {08},
  pages = {1035--1042},
  doi = {10.1055/a-2452-8220}
}
Kostenlos starten →